Abstract
In this project, the objective is the synthesis and characterization of a novel trinuclear ruthenium acetate [Ru3O(CH3COO)6(THIQ)2(CH3OH)]PF6 (where THIQ = 5,6,7,8-tetrahydroisoquinoline) in order to study its interaction with human serum albumin (HSA), with the aim of obtaining a complex:HSA adduct in the future, which would function as a drug candidate carrier. For the characterization …